Publications by authors named "A Loftenius"

Claim this Profile
E
Evaluation of a novel Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile.
Yongsheng Liu, Maryam Oroujeni, Yunqi Liao, Anzhelika Vorobyeva, Vitalina Bodenko, Annika Loftenius

Eur J Nucl Med Mol Imaging· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy.
Nina Eissler, Renske Altena, Ali Alhuseinalkhudhur, Olga Bragina, Joachim Feldwisch, Annika Loftenius

Biomedicines· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical evaluation of Tc-labeled Affibody molecule for imaging HER2 expression in breast cancer.
Olga Bragina, Vladimir Chernov, Mariia Larkina, Anstasiya Rybina, Roman Zelchan, Annika Loftenius

Theranostics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab.
Yongsheng Liu, Tianqi Xu, Anzhelika Vorobyeva, Annika Loftenius, Vitalina Bodenko

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule Re-ZHER2:41071.
Yongsheng Liu, Anzhelika Vorobyeva, Anna Orlova, Mark W Konijnenberg, Tianqi Xu, Annika Loftenius

Pharmaceutics· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis